Literature DB >> 25449529

Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions.

James Varley1, David J Brooks1, Paul Edison2.   

Abstract

Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia (FTD), and Huntington's disease (HD) are the main neurodegenerative causes of dementia. Causes and mechanisms of these diseases remain elusive. Neuroinflammation is increasingly emerging as an important pathological factor in their development. Positron emission tomography (PET) using [11C]PK11195 represents a method of visualizing the microglial component of neuroinflammation via the translocator protein (TSPO) and we discuss the valuable insights this has yielded in neurodegenerative diseases. We discuss the limitations of this method and the development of second generation TSPO PET ligands which hope to overcome these limitations. We also discuss other methods of visualizing neuroinflammation and review the state of current dementia treatments targeted at neuroinflammation. It is our view that a multimodal investigation into neuroinflammation in AD, Parkinson's disease dementia, FTD and HD will yield valuable pathological insights which will usefully inform development of therapeutic targets and biomarkers.
Copyright © 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Dementia; MRI; Microglial activation; Neurodegenerative disease; PET; TSPO; neuroinflammation

Mesh:

Substances:

Year:  2014        PMID: 25449529     DOI: 10.1016/j.jalz.2014.08.105

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  30 in total

Review 1.  Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Kirk A Frey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-14       Impact factor: 5.081

Review 2.  Neuroinflammation, Gut Microbiome, and Alzheimer's Disease.

Authors:  Li Lin; Li Juan Zheng; Long Jiang Zhang
Journal:  Mol Neurobiol       Date:  2018-03-09       Impact factor: 5.590

Review 3.  A short perspective on the long road to effective treatments for Alzheimer's disease.

Authors:  David S Reynolds
Journal:  Br J Pharmacol       Date:  2019-03-01       Impact factor: 8.739

Review 4.  Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases.

Authors:  Md Maqusood Alam; Jihye Lee; Sang-Yoon Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-03-16

Review 5.  Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system.

Authors:  Ruiqing Ni; Linjing Mu; Simon Ametamey
Journal:  Acta Pharmacol Sin       Date:  2018-06-19       Impact factor: 6.150

6.  An early and late peak in microglial activation in Alzheimer's disease trajectory.

Authors:  Zhen Fan; David J Brooks; Aren Okello; Paul Edison
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

Review 7.  miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases.

Authors:  Jinying Xu; Yangyang Zheng; Yulin Li; Guangfan Chi; Liangjia Wang; Yining Liu; Xishu Wang
Journal:  Cell Mol Neurobiol       Date:  2021-04-22       Impact factor: 4.231

8.  Upregulation of PLZF is Associated with Neuronal Injury in Lipopolysaccharide-Induced Neuroinflammation.

Authors:  Mingqing He; Yonghua Liu; Jiabing Shen; Chengwei Duan; Xiang Lu
Journal:  Neurochem Res       Date:  2016-08-19       Impact factor: 4.414

Review 9.  Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT.

Authors:  Lieven D Declercq; Rik Vandenberghe; Koen Van Laere; Alfons Verbruggen; Guy Bormans
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

10.  Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.

Authors:  Michael Schöll; Stephen F Carter; Eric Westman; Elena Rodriguez-Vieitez; Ove Almkvist; Steinunn Thordardottir; Anders Wall; Caroline Graff; Bengt Långström; Agneta Nordberg
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.